Mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation stabilizes ISCU protein: Implications for iron metabolism

Journal of Biological Chemistry

Volumn 288, Issue 18, 2013, Pages 12901-12909

  La, Ping ^a   Yang, Guang ^a   Dennery, Phyllis A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COFACTORS; COMPLEX 1; IRON METABOLISM; IRON-SULFUR CLUSTERS; MAMMALIAN TARGET; METABOLIC PROCESS; PROTEIN LEVEL; SCAFFOLD PROTEIN;

AMINO ACIDS; ANTIBIOTICS; IRON; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEINS;

IRON COMPOUNDS;

IRON SULFUR PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; SERINE;

ANIMAL CELL; ARTICLE; BIOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IRON METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

IRON-SULFUR CLUSTERS; IRON-SULFUR PROTEIN; ISCU; METABOLISM; MTOR; PHOSPHORYLATION; TUBEROUS SCLEROSIS (TSC);

3T3-L1 CELLS; ANIMALS; HELA CELLS; HOMEOSTASIS; HUMANS; IRON; IRON-SULFUR PROTEINS; MICE; PHOSPHORYLATION; PROTEIN STABILITY; PROTEINS; TOR SERINE-THREONINE KINASES;

MAMMALIA;

EID: 84877146678     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.424499     Document Type: Article

References (30)

1. Ye, H., and Rouault, T. A. (2010) Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 49, 4945-4956
2. Tong, W. H., and Rouault, T. (2000) Distinct iron-sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells. EMBO J. 19, 5692-5700
3. Olsson, A., Lind, L., Thornell, L. E., and Holmberg, M. (2008) Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect. Hum. Mol. Genet. 17, 1666-1672 (Pubitemid 351737170)
4. Nordin, A., Larsson, E., Thornell, L. E., and Holmberg, M. (2011) Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice. Hum. Genet. 129, 371-378
5. Chan, S. Y., Zhang, Y. Y., Hemann, C., Mahoney, C. E., Zweier, J. L., and Loscalzo, J. (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10, 273-284
6. Chen, Z., Li, Y., Zhang, H., Huang, P., and Luthra, R. (2010) Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29, 4362-4368
7. Tong, W. H., and Rouault, T. A. (2006) Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab. 3, 199-210
8. Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35
9. Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y. L., and Schulze, A. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224-236
10. Yoshikura, H., and Hirokawa, Y. (1974) Endogenous C-type virus of a mouse cell line and its defectiveness. J. Virol. 13, 1319-1325
11. Kwiatkowski, D. J., and Manning, B. D. (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14, R251-258 (Pubitemid 41631882)
12. Student, A. K., Hsu, R. Y., and Lane, M. D. (1980) Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J. Biol. Chem. 255, 4745-4750 (Pubitemid 10060752)
13. Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., Marto, J. A., and Sabatini, D. M. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322
14. Yu, Y., Yoon, S. O., Poulogiannis, G., Yang, Q., Ma, X. M., Villén, J., Kubica, N., Hoffman, G. R., Cantley, L. C., Gygi, S. P., and Blenis, J. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326
15. Gauci, S., Helbig, A. O., Slijper, M., Krijgsveld, J., Heck, A. J., and Mohammed, S. (2009) Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal. Chem. 81, 4493-4501
16. Mayya, V., Lundgren, D. H., Hwang, S. I., Rezaul, K., Wu, L., Eng, J. K., Rodionov, V., and Han, D. K. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal 2, ra46
17. Tzatsos, A., and Kandror, K. V. (2006) Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol. Cell Biol. 26, 63-76
18. Shor, B., Wu, J., Shakey, Q., Toral-Barza, L., Shi, C., Follettie, M., and Yu, K. (2010) Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. J. Biol. Chem. 285, 15380-15392
19. Wang, L., Harris, T. E., and Lawrence, J. C., Jr. (2008) Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. J. Biol. Chem. 283, 15619-15627
20. Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., Lane, W. S., and Schreiber, S. L. (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758
21. Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B., Latham, V., and Sullivan, M. (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-270
22. 2+ revealed by specifically targeted recombinant aequorin. Nature 358, 325-327
23. Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., Chang, L., Zhang, Y., Goto, J., Onda, H., Chen, T., Wang, M. R., Lu, Y., You, H., Kwiatkowski, D., and Zhang, H. (2011) Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc. Natl. Acad. Sci. U.S.A. 108, 4129-4134
24. Matouschek, A., Azem, A., Ratliff, K., Glick, B. S., Schmid, K., and Schatz, G. (1997) Active unfolding of precursor proteins during mitochondrial protein import. EMBO J. 16, 6727-6736 (Pubitemid 27503485)
25. Johnson, C., Tinti, M., Wood, N. T., Campbell, D. G., Toth, R., Dubois, F., Geraghty, K. M., Wong, B. H., Brown, L. J., Tyler, J., Gernez, A., Chen, S., Synowsky, S., and MacKintosh, C. (2011) Visualization and biochemical analyses of the emerging mammalian 14-3-3-phosphoproteome. Mol. Cell. Proteomics 10, 10.1074/mcp.M110.005751
26. Yokogami, K., Wakisaka, S., Avruch, J., and Reeves, S. A. (2000) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10, 47-50 (Pubitemid 30057415)
27. Choo, A. Y., Kim, S. G., Vander Heiden, M. G., Mahoney, S. J., Vu, H., Yoon, S. O., Cantley, L. C., and Blenis, J. (2010) Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol. Cell 38, 487-499
28. Zhou, T., Ma, Y., Kong, X., and Hider, R. C. (2012) Design of iron chelators with therapeutic application. Dalton Trans. 41, 6371-6389
29. Sofroniadou, S., and Goldsmith, D. (2011) Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects. Drug Saf. 34, 97-115
30. Ye, H., and Rouault, T. A. (2010) Erythropoiesis and iron sulfur cluster biogenesis. Adv. Hematol. 2010, 329394